Our Mission

To transform the lives of patients living with autoimmune diseases.

Our Pipeline

Rapidly advancing a deep portfolio of innovative autoimmune therapeutics that continues to expand through our successful business development strategy.

Latest News

May 7, 2024

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

March 6, 2024

Zenas BioPharma Appoints Patricia Allen to its Board of Directors